In HL cell lines (95.5% for L428, 95.3% for KMH2, and 92.3% for HDLM2), we found a correlation between MSI and the co-expression of CD30+/CD15+, one of the clinical hallmarks of HL. This evidence concerns the gene FUT4 and Hodgkins lymphoma.